Comments
Loading...

Immunovant

IMVTNASDAQ
Logo brought to you by Benzinga Data
Q2 2025 Earnings were released on Thu Nov 7th, before the market open

Immunovant (NASDAQ:IMVT) Stock Quotes, Forecast and News Summary

Immunovant Stock (NASDAQ: IMVT) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
2
Aug
1
Sep
2
Oct
0
0
0
0
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$29.93
Close-
Volume / Avg.251.05K / 848.05K
Day Range$29.67 - $31.26
52 Wk Range24.67 - 45.58
Market Cap$4.55B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
56
Short Interest
20.08%
Days to Cover20.12

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
IMVT
RNA

FAQ

Q

How do I buy Immunovant (IMVT) stock?

A

You can purchase shares of Immunovant (NASDAQ:IMVT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Immunovant (IMVT) competitors?

Q

What is the forecast, or price target, for Immunovant (IMVT) stock?

A

Immunovant has a consensus price target of $40.68.

Q

What is the current price for Immunovant (IMVT)?

A

The stock price for Immunovant (NASDAQ: IMVT) is $30.99 last updated November 8, 2024 at 12:04 PM EST.

Q

Does Immunovant (IMVT) pay a dividend?

A

There are no upcoming dividends for Immunovant.

Q

When is Immunovant (NASDAQ:IMVT) reporting earnings?

A

Immunovant’s Q2 earnings are confirmed for Thursday, November 7, 2024.

Q

Is Immunovant (IMVT) going to split?

A

There is no upcoming split for Immunovant.

Q

What sector and industry does Immunovant (IMVT) operate in?

A

Immunovant is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch